BioCentury | Dec 22, 2017
Company News

Cyclenium, Ono partner for macrocycles

...are undisclosed. Cyclenium Pharma Inc., Sherbrooke, Quebec Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Business: Pharmaceuticals Elizabeth S. Eaton Cyclenium Pharma Inc. Ono...
BioCentury | Jul 13, 2015
Company News

Cyclenium Pharma, Haplogen deal

...technology for host target identification, validation and screening. The companies declined to disclose financial terms. Cyclenium Pharma Inc....
BioCentury | Jun 29, 2015
Company News

Cyclenium Pharma, McGill University deal

...interacting with specific therapeutic targets, including protein-protein interactions. The partners declined to disclose financial terms. Cyclenium Pharma Inc....
BioCentury | Jun 15, 2015
Company News

Astellas, Cyclenium Pharma deal

...disclose details on the targets, indications or financial terms. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Cyclenium Pharma Inc....
BioCentury | Mar 9, 2015
Company News

Fundacion Medina, Cyclenium Pharma deal

...disclose financial details, and Medina did not respond to inquiries. Fundacion Medina , Granada, Spain Cyclenium Pharma Inc....
BioCentury | Apr 28, 2014
Company News

Cyclenium Pharma, Southern Research Institute deal

...declined to disclose financial terms, said they will share any IP generated through the deal. Cyclenium Pharma Inc....
Items per page:
1 - 6 of 6
BioCentury | Dec 22, 2017
Company News

Cyclenium, Ono partner for macrocycles

...are undisclosed. Cyclenium Pharma Inc., Sherbrooke, Quebec Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Business: Pharmaceuticals Elizabeth S. Eaton Cyclenium Pharma Inc. Ono...
BioCentury | Jul 13, 2015
Company News

Cyclenium Pharma, Haplogen deal

...technology for host target identification, validation and screening. The companies declined to disclose financial terms. Cyclenium Pharma Inc....
BioCentury | Jun 29, 2015
Company News

Cyclenium Pharma, McGill University deal

...interacting with specific therapeutic targets, including protein-protein interactions. The partners declined to disclose financial terms. Cyclenium Pharma Inc....
BioCentury | Jun 15, 2015
Company News

Astellas, Cyclenium Pharma deal

...disclose details on the targets, indications or financial terms. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Cyclenium Pharma Inc....
BioCentury | Mar 9, 2015
Company News

Fundacion Medina, Cyclenium Pharma deal

...disclose financial details, and Medina did not respond to inquiries. Fundacion Medina , Granada, Spain Cyclenium Pharma Inc....
BioCentury | Apr 28, 2014
Company News

Cyclenium Pharma, Southern Research Institute deal

...declined to disclose financial terms, said they will share any IP generated through the deal. Cyclenium Pharma Inc....
Items per page:
1 - 6 of 6